文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

用于核酸递送的光触发纳米载体。

Light-triggered nanocarriers for nucleic acid delivery.

作者信息

Huang Baihao, De Smedt Stefaan C, De Vos Winnok H, Braeckmans Kevin

机构信息

Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.

Laboratory of Cell Biology and Histology, Department of Veterinary Sciences, University of Antwerp, Antwerp, Belgium.

出版信息

Drug Deliv. 2025 Dec;32(1):2502346. doi: 10.1080/10717544.2025.2502346. Epub 2025 May 14.


DOI:10.1080/10717544.2025.2502346
PMID:40366876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12082745/
Abstract

Gene therapy has evolved into a clinically viable strategy, with several approved products demonstrating its therapeutic potential for genetic disorders, cancer, and infectious diseases, and it has ample applications in regenerative medicine. Its success depends on the ability to efficiently and specifically deliver therapeutic nucleic acids (NAs) into target cells. Although viral or chemical carriers have been used in pioneering applications, safety concerns, and variable delivery efficiencies have prompted the search for alternative delivery vehicles. Light-mediated strategies have gained particular interest due to their biocompatibility and ability to improve the intracellular delivery efficiency. In this review, we focus on recent advancements in the development of light-triggered NA delivery carriers and discuss how they can be designed to overcome specific intracellular barriers. Additionally, we discuss notable therapeutic applications and highlight challenges and opportunities for translating this technology to a clinical setting.

摘要

基因治疗已发展成为一种具有临床可行性的策略,有几种获批产品展示了其在治疗遗传疾病、癌症和传染病方面的治疗潜力,并且在再生医学中有广泛应用。其成功取决于能否高效且特异性地将治疗性核酸(NAs)递送至靶细胞。尽管病毒或化学载体已用于开创性应用,但安全问题和可变的递送效率促使人们寻找替代递送载体。光介导策略因其生物相容性和提高细胞内递送效率的能力而备受关注。在本综述中,我们重点关注光触发核酸递送载体开发的最新进展,并讨论如何设计它们以克服特定的细胞内障碍。此外,我们还讨论了显著的治疗应用,并强调了将该技术转化为临床应用所面临的挑战和机遇。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/f8f02f1990a3/IDRD_A_2502346_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/615b88d7e654/IDRD_A_2502346_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/c24022b4135d/IDRD_A_2502346_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/1eb416118ed7/IDRD_A_2502346_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/c620f04f755c/IDRD_A_2502346_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/f8f02f1990a3/IDRD_A_2502346_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/615b88d7e654/IDRD_A_2502346_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/c24022b4135d/IDRD_A_2502346_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/1eb416118ed7/IDRD_A_2502346_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/c620f04f755c/IDRD_A_2502346_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/12082745/f8f02f1990a3/IDRD_A_2502346_F0005_C.jpg

相似文献

[1]
Light-triggered nanocarriers for nucleic acid delivery.

Drug Deliv. 2025-12

[2]
Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation.

Acc Chem Res. 2025-7-1

[3]
Management of urinary stones by experts in stone disease (ESD 2025).

Arch Ital Urol Androl. 2025-6-30

[4]
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.

J Psychiatr Ment Health Nurs. 2024-8

[5]
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges.

J Nanobiotechnology. 2025-6-18

[6]
Short-Term Memory Impairment

2025-1

[7]
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.

JBI Database System Rev Implement Rep. 2016-4

[8]
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.

Cochrane Database Syst Rev. 2022-4-26

[9]
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.

Respir Res. 2024-12-21

[10]
Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods.

Cochrane Database Syst Rev. 2015-7-27

本文引用的文献

[1]
NIR-II-excited off-on-off fluorescent nanoprobes for sensitive molecular imaging in vivo.

Nat Commun. 2025-1-2

[2]
A photothermal surface modified with polyelectrolyte multilayers for gene transfection and cell harvest.

Colloids Surf B Biointerfaces. 2024-10

[3]
Nanomaterials for light-mediated therapeutics in deep tissue.

Chem Soc Rev. 2024-3-18

[4]
Fluoropolymer Coated DNA Nanoclews for Volumetric Visualization of Oligonucleotides Delivery and Near Infrared Light Activated Anti-Angiogenic Oncotherapy.

Adv Sci (Weinh). 2023-11

[5]
Two-Photon Light Trigger siRNA Transfection of Cancer Cells Using Non-Toxic Porous Silicon Nanoparticles.

Adv Healthc Mater. 2023-10

[6]
ROS-Responsive Nanoparticle Delivery of mRNA and Photosensitizer for Combinatorial Cancer Therapy.

Nano Lett. 2023-5-10

[7]
Activatable NIR-II Photothermal Lipid Nanoparticles for Improved Messenger RNA Delivery.

Angew Chem Int Ed Engl. 2023-6-19

[8]
Light-Activated siRNA Endosomal Release (LASER) by Porphyrin Lipid Nanoparticles.

ACS Nano. 2023-3-14

[9]
Synthesis of multi-branched Au nanocomposites with distinct plasmon resonance in NIR-II window and controlled CRISPR-Cas9 delivery for synergistic gene-photothermal therapy.

Biomaterials. 2022-8

[10]
Nanodelivery of nucleic acids.

Nat Rev Methods Primers. 2022

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索